We reasoned here that integration of potent heterologous repression domains (RDs) into EBM could generate monotransrepressors that alter ERE-bearing gene expressions and cellular proliferation in directions opposite to those observed with E2-ERα or monotransactivators.

So long! See you soon! Too-ra-loo!

Some forth their cabins peepe.

Even the spade-handed moles shall declare their folly.